John Andrew Chaddock

Part of Ipsen SA, Ipsen Biopharm Ltd. is a British biopharmaceutical company that aims to prolong patients' lives, improve health outcomes, and create a positive impact for patients and society. Founded in 1982, the company is based in Wrexham, UK. Ipsen specializes in the fields of oncology, neuroscience, and rare disease, and creates and manufactures pharmaceutical products to improve patients' lives through research and innovation.

Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom.